Amphastar Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $1.63B
Liabilities Breakdown FY2025
Total Liabilities: $840.5M
Asset Breakdown
Total Assets: $1.63B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $170.2M | 10.4% |
| Accounts Receivable | $143.6M | 8.8% |
| Inventory | $176.9M | 10.9% |
| Property, Plant & Equipment | $310.6M | 19.1% |
| Goodwill | $3.4M | 0.2% |
| Intangible Assets | $533.3M | 32.7% |
| Other Assets | $291.4M | 17.9% |
Liabilities Breakdown
Total Liabilities: $840.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $32.6M | 3.9% |
| Long-Term Debt | $619.7M | 73.7% |
| Other Liabilities | $188.2M | 22.4% |